353 related articles for article (PubMed ID: 27510996)
1. [Autologous stem cell transplantation in systemic sclerosis].
Henes JC; Wirths S; Kötter I
Z Rheumatol; 2016 Oct; 75(8):762-769. PubMed ID: 27510996
[TBL] [Abstract][Full Text] [Related]
2. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
3. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Binks M; Passweg JR; Furst D; McSweeney P; Sullivan K; Besenthal C; Finke J; Peter HH; van Laar J; Breedveld FC; Fibbe WE; Farge D; Gluckman E; Locatelli F; Martini A; van den Hoogen F; van de Putte L; Schattenberg AV; Arnold R; Bacon PA; Emery P; Espigado I; Hertenstein B; Hiepe F; Kashyap A; Kötter I; Marmont A; Martinez A; Pascual MJ; Gratwohl A; Prentice HG; Black C; Tyndall A
Ann Rheum Dis; 2001 Jun; 60(6):577-84. PubMed ID: 11350846
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem-cell transplantation in systemic sclerosis: an update.
Spierings J; van Rhijn-Brouwer FCC; van Laar JM
Curr Opin Rheumatol; 2018 Nov; 30(6):541-547. PubMed ID: 30063470
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapies for systemic sclerosis.
Cipriani P; Ruscitti P; Giacomelli R
Br J Haematol; 2015 Feb; 168(3):328-37. PubMed ID: 25376920
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.
Burt RK; Milanetti F
Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226
[TBL] [Abstract][Full Text] [Related]
7. [Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus].
Alexander T; Arnold R; Hiepe F
Z Rheumatol; 2016 Oct; 75(8):770-779. PubMed ID: 27612476
[TBL] [Abstract][Full Text] [Related]
8. The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Rebeiro P; Moore J
Intern Med J; 2016 Jan; 46(1):17-28. PubMed ID: 26524106
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens.
Oyama Y; Traynor AE; Barr W; Burt RK
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S81-3. PubMed ID: 12931250
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
11. Autologous Hematological Stem Cell Transplantation for Systemic Sclerosis in Israel.
Rimar D; Butbul Aviel Y; Gefen A; Nevo N; Shen-Orr SS; Starosvetsky E; Rosner I; Rozenbaum M; Kaly L; Boulman N; Slobodin G; Zuckerman T
Isr Med Assoc J; 2020 Feb; 22(2):104-110. PubMed ID: 32043328
[TBL] [Abstract][Full Text] [Related]
12. Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis.
van Laar JM; Naraghi K; Tyndall A
Rheumatology (Oxford); 2015 Dec; 54(12):2126-33. PubMed ID: 25953700
[TBL] [Abstract][Full Text] [Related]
13. The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis.
Burt RK; Patel D; Thomas J; Yeager A; Traynor A; Heipe F; Arnold R; Marmont A; Collier D; Glatstein E; Snowden J
Bone Marrow Transplant; 2004 Nov; 34(9):745-51. PubMed ID: 15361910
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of autologous haematopoietic stem cell transplantation in systemic sclerosis: a systematic review of the literature.
Eyraud A; Scouppe L; Barnetche T; Forcade E; Lazaro E; Duffau P; Richez C; Seneschal J; Truchetet ME;
Br J Dermatol; 2018 Mar; 178(3):650-658. PubMed ID: 28906550
[TBL] [Abstract][Full Text] [Related]
15. Haematopoietic stem cell transplantation for autoimmune diseases.
Swart JF; Delemarre EM; van Wijk F; Boelens JJ; Kuball J; van Laar JM; Wulffraat NM
Nat Rev Rheumatol; 2017 Apr; 13(4):244-256. PubMed ID: 28228650
[TBL] [Abstract][Full Text] [Related]
16. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial.
Burt RK; Shah SJ; Dill K; Grant T; Gheorghiade M; Schroeder J; Craig R; Hirano I; Marshall K; Ruderman E; Jovanovic B; Milanetti F; Jain S; Boyce K; Morgan A; Carr J; Barr W
Lancet; 2011 Aug; 378(9790):498-506. PubMed ID: 21777972
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis.
Vonk MC; Marjanovic Z; van den Hoogen FH; Zohar S; Schattenberg AV; Fibbe WE; Larghero J; Gluckman E; Preijers FW; van Dijk AP; Bax JJ; Roblot P; van Riel PL; van Laar JM; Farge D
Ann Rheum Dis; 2008 Jan; 67(1):98-104. PubMed ID: 17526554
[TBL] [Abstract][Full Text] [Related]
18. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
19. Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy.
Nakamura H; Odani T; Yasuda S; Noguchi A; Fujieda Y; Kato M; Oku K; Bohgaki T; Sugita J; Endo T; Teshima T; Atsumi T
Mod Rheumatol; 2018 Sep; 28(5):879-884. PubMed ID: 29251023
[TBL] [Abstract][Full Text] [Related]
20. Stem cell transplantation in systemic sclerosis.
van Laar JM; Sullivan K
Curr Opin Rheumatol; 2013 Nov; 25(6):719-25. PubMed ID: 24047607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]